Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:19 PM
Ignite Modification Date:
2026-03-26 @ 3:19 PM
NCT ID:
NCT07432360
Eligibility Criteria:
Inclusion Criteria:
* Humans with a prostate ≥18 years of age.
* Patients with biopsy-proven PCa who are scheduled for an RPE.
* Signed informed consent form (ICF) that demonstrates study participant understands the purpose of and procedures necessary for the study.
* Willingness, ability, and legal capacity to participate in the study.
* Ability to adhere to the prohibitions and restrictions defined in this protocol.
Exclusion Criteria:
* Inability to give consent.
* Prior hormone treatment (i.e., androgen deprivation treatment (ADT) and/or 5-ɑ-reductase inhibitors).
* Prior PCa treatment.
* Prior transurethral resection of the prostate (TUR-P) or other prostate surgery.
* Prior total hip arthroplasty on one or both sides or other metal implants that interfere with the MRI acquisition of the hip region.
* General contraindications for an MRI scan (i.e., pacemaker, relevant metal implants, etc.).
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT07432360
Study Brief:
Protocol Section:
NCT07432360